EFPIA - NEWSLETTER

Trouble reading this email? View it in your browser


		EFPIA Newsletter 27 April 2023

EFPIA responses to the EU pharma legislation and patent package proposal

EU pharma-legislation risks sabotaging Europe’s life science industry putting European patients...
26 April 2023

The publication of the EU pharmaceutical legislation is an important milestone as the EU, Member States and industry strive to improve access to medicines and vaccines, and reinvigorate science and innovation in Europe. Unfortunately, this week's proposal manages to undermine research and development in Europe while failing to address access to medicines for patients.

Read the full EFPIA response to the publication of the EU pharma legislation. Read more

EFPIA response to the European Commission’s patent package proposal
27 April 2023

Following proposals that will weaken the EU’s intellectual property framework in yesterday’s EU Pharmaceutical Legislation [26 April 2023], today’s release of the patent package proposal provides some positives, but also considerable concerns and uncertainty for companies operating in the region.

Read the full EFPIA response to the European Commission’s patent package proposal. Read more

News

IHI seeks patients and caregivers to contribute to its activities
27 April 2023

IHI is calling on patients and informal caregivers to apply to be part of a new IHI Patient Pool which will strengthen... Read more

Events

Faster, more equitable access to medicines across Europe (1)
28 April 2023 (Virtual event)

We believe that faster, more equitable access in Europe is an achievable goal. It requires a shared understanding of... Read more

Webinar on the IHI Patient Pool
11 May 2023 (Virtual)

IHI will hold a webinar on the Patient Pool. This webinar is designed to help potential applicants prepare their expression... Read more

Realising the potential of the European Health Data Space for Innovation
30 May 2023 (Residence Palace, Rue de la Loi 155, 1040 Brussels)

EFPIA and COPAC are pleased to invite you to an in-person discussion on the key issues that are fundamental in ensuring... Read more

How the pharmaceutical industry is working to avoid and replace the use of animals for scientific...
22 June 2023 (Zoom)

An online event co-organised by EFPIA and the RSPCA Read more

What we are reading

It’s time that Europe makes up for lost ground in biopharmaceutical innovation
On 21 April 2023 (Farmaindustria)

Farmaindustria hosted a meeting bringing together over 20 members of National Associations in Europe representing innovative... Read more

Mandatory application of the CTR in the EU
On 26 April 2023 (EMA)

This commercial sponsor perspective was developed by clinical trial experts from a working group of pharmaceutical companies... Read more

EPF TURNS 20
On 28 April 2023 (EPF)

20 years of highly effective advocacy campaigns. 20 years of unique multistakeholder collaboration. 20 years of ensuring... Read more

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
E-mail:Communications@efpia.eu